@article{Hou2018, 
author = {Li Hou and Liya Ju and Jing Wang and Tian Zhou and Yang Shen and Jiaqi Chi and Jean-Pierre Armand and Anlong Xu and Kaiwen Hu},
title = {Use of traditional Chinese medicine in the treatment of immune-related adverse events of cancer immunotherapy},
year = {2018},
journal = {Journal of Traditional Chinese Medical Sciences},
volume = {5},
number = {4},
pages = {323-327},
keywords = {Immune-related adverse events, Traditional Chinese medicine, Cancer immunotherapy, Immune checkpoint inhibitors},
url = {https://www.sciopen.com/article/10.1016/j.jtcms.2018.12.002},
doi = {10.1016/j.jtcms.2018.12.002},
abstract = {Immune checkpoint inhibitors (ICPI) have shown considerable promise in the treatment of tumors. However, immune-related adverse events (irAEs) caused by ICPI have been reported in nearly every organ system. Whilst this represents a new challenge in the field of cancer treatment, traditional Chinese medicine (TCM) provides benefits in the treatment of irAEs. This article reviews the studies of the treatment of immune-related gastrointestinal diseases and dermatosis with TCM and introduces the collaborative efforts between China and France in the implementation of TCM for the treatment of irAEs.}
}